Anti SSTR2 pAb (ATL-HPA007264 w/enhanced validation)
Atlas Antibodies
- Catalog No.:
- ATL-HPA007264-25
- Shipping:
- Calculated at Checkout
$423.00
Gene Name: SSTR2
Alternative Gene Name:
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000047904: 98%, ENSRNOG00000002793: 96%
Entrez Gene ID: 6752
Uniprot ID: P30874
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
| Product Specifications | |
| Application | WB, ICC, IHC |
| Reactivity | Human |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | DNFKKSFQNVLCLVKVSGTDDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI |
| Gene Sequence | DNFKKSFQNVLCLVKVSGTDDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI |
| Gene ID - Mouse | ENSMUSG00000047904 |
| Gene ID - Rat | ENSRNOG00000002793 |
| Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
| Documents & Links for Anti SSTR2 pAb (ATL-HPA007264 w/enhanced validation) | |
| Datasheet | Anti SSTR2 pAb (ATL-HPA007264 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti SSTR2 pAb (ATL-HPA007264 w/enhanced validation) at Atlas Antibodies |
| Documents & Links for Anti SSTR2 pAb (ATL-HPA007264 w/enhanced validation) | |
| Datasheet | Anti SSTR2 pAb (ATL-HPA007264 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti SSTR2 pAb (ATL-HPA007264 w/enhanced validation) |
| Citations for Anti SSTR2 pAb (ATL-HPA007264 w/enhanced validation) – 4 Found |
| Tran, Catherine G; Borbon, Luis C; Mudd, Jacqueline L; Abusada, Ellen; AghaAmiri, Solmaz; Ghosh, Sukhen C; Vargas, Servando Hernandez; Li, Guiying; Beyer, Gabriella V; McDonough, Mary; Li, Rachel; Chan, Carlos H F; Walsh, Susan A; Wadas, Thaddeus J; O'Dorisio, Thomas; O'Dorisio, M Sue; Govindan, Ramaswamy; Cliften, Paul F; Azhdarinia, Ali; Bellizzi, Andrew M; Fields, Ryan C; Howe, James R; Ear, Po Hien. Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy. Cancers. 2022;14(8) PubMed |
| Minner, Sarah; Enodien, Malaika; Sirma, Hüseyin; Luebke, Andreas M; Krohn, Antje; Mayer, Pascale S; Simon, Ronald; Tennstedt, Pierre; Müller, Julia; Scholz, Laura; Brase, Jan C; Liu, Alvin Y; Schlüter, Hartmut; Pantel, Klaus; Schumacher, Udo; Bokemeyer, Carsten; Steuber, Thomas; Graefen, Markus; Sauter, Guido; Schlomm, Thorsten. ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research. 2011;17(18):5878-88. PubMed |
| Erlandsson, Ann; Forssell-Aronsson, Eva; Seidal, Tomas; Bernhardt, Peter. Binding of TS1, an anti-keratin 8 antibody, in small-cell lung cancer after 177Lu-DOTA-Tyr3-octreotate treatment: a histological study in xenografted mice. Ejnmmi Research. 2011;1(1):19. PubMed |
| Hennigs, Jan K; Müller, Julia; Adam, Matti; Spin, Joshua M; Riedel, Emilia; Graefen, Markus; Bokemeyer, Carsten; Sauter, Guido; Huland, Hartwig; Schlomm, Thorsten; Minner, Sarah. Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapse. Plos One. 9(7):e100469. PubMed |